Patient Decision Aid for Antidepressant Use in Pregnancy
Depression, Pregnancy

About this trial
This is an interventional other trial for Depression
Eligibility Criteria
INCLUSION CRITERIA: Women who meet all of the following criteria:
- Are aged over 18
- Are planning a pregnancy or are <30 weeks pregnant at enrolment
- Have been offered to start or continue an antidepressant as treatment for depression by their clinician a
- Have moderate-to-high decisional conflict (score of >25 on the Decisional Conflict Scale)
EXCLUSION CRITERIA: Women who meet any of the following criteria:
- Have had alcohol or drug abuse or dependence in the previous 12 months
- Have active suicidal ideation or psychosis
- Are incapable of consenting to participation
- Have any major obstetric complications or foetal cardiac anomaly in the current or in a past pregnancy,
- Are visually impaired
- Do not have sufficient English language proficiency to use the PDA.
Sites / Locations
- South London and Maudsley NHS Foundation Trust
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Active Comparator
Standard Resource Sheet
Electronic Patient Decision Aid
Women allocated to the control intervention will login to the study website and receive a printable PDF containing references to standard published information on antidepressant use in pregnancy. This ensures women have access to accurate information on the benefits and risks of antidepressant medication in pregnancy (even though they will not receive the PDA).
The electronic Patient Decision Aid (PDA) is an interactive website with 3 main sections: Evidence-based information on (a) depression in pregnancy, (b) each treatment option and procedure; (a) Evidence-based information on the risks and benefits of both untreated depression and antidepressant treatment, (b) exercises to help women determine which risks and benefits are most important to them; and A summary section that outlines the information reviewed and which benefits and risks they deemed most important. At the end of the PDA, women allocated to this intervention will ALSO receive the standard resource sheet which is being used as the placebo comparator.